They showed increase in serum IL-17 and IL-23 levels as well as IL-17 and IL-23 mRNA expression in peripheral blood lymphocytes of patients with MDD (n=190) compared with the control group (n=100) (43). This evidence concerns the gene IL17A and major depressive disorder.